Experience with the use of perilesional and intralesional recombinant human epidermal growth factor (nepidermin) in the treatment of patients with chronic venous ulcers

Background. Venous ulcers are a serious and highly recurring health problem that cause significant impact on the population. Currently, there are several treatment options available; however, they still entail a great therapeutic challenge, generating implications to the patient's health and qu...